SCHEMBL19196288

SCHEMBL19196288

C(=C/c1nc(-c2cccc(-c3ccccc3)c2)cs1)\c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.43
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HPGD P15428 1/20 0.41
POLB P06746 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17336957 0.88 KMO (0.51) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL17336959 0.88 KMO (0.51) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL5777558 0.81 CYP19A1 (0.54) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL9514540 0.81 ALOX5 (0.51) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL9514548 0.81 ALOX5 (0.51) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL9514841 0.81 CYP19A1 (0.54) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL28479905 0.80 MAPT (0.50) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL28480298 0.79 KMT2A (0.54) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL7478870 0.78 NR1H4 (0.52) PARP1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL7478874 0.78 NR1H4 (0.52) PARP1ALDH1A1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969726-B2 Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-05-15 US disclosed
US-20170217951-A1 Metabotropic Glutamate Receptor Negative Allosteric Modulators (NAMS) and Uses Thereof SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217951-A1 Metabotropic Glutamate Receptor Negative Allosteric Modulators (NAMS) and Uses Thereof GRM3, GRM2, GRM1 PARP1 4246/4885ALDH1A1 4541/4885KDM4E 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.